ORVR.F Stock Overview
Engages in the design, development, manufacturing, branding, and distribution of cannabis vape products in North America. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Orchid Ventures, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.000001 |
| 52 Week High | US$0.000001 |
| 52 Week Low | US$0.000001 |
| Beta | 0 |
| 11 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 33 Year Change | -100.00% |
| 5 Year Change | -100.00% |
| Change since IPO | -100.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| ORVR.F | US Pharmaceuticals | US Market | |
|---|---|---|---|
| 7D | 0% | 4.2% | 2.0% |
| 1Y | n/a | 13.7% | 32.4% |
Return vs Industry: Insufficient data to determine how ORVR.F performed against the US Pharmaceuticals industry.
Return vs Market: Insufficient data to determine how ORVR.F performed against the US Market.
Price Volatility
| ORVR.F volatility | |
|---|---|
| ORVR.F Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 9.7% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 15.9% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: ORVR.F has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine ORVR.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | Corey Mangold | www.orchidessentials.com |
Orchid Ventures, Inc. engages in the design, development, manufacturing, branding, and distribution of cannabis vape products in North America. It provides cannabis vapor devices, such as kits and cartridges. The company offers its products through approximately 150 dispensaries across California and Oregon.
Orchid Ventures, Inc. Fundamentals Summary
| ORVR.F fundamental statistics | |
|---|---|
| Market cap | US$52.00 |
| Earnings (TTM) | -US$3.16m |
| Revenue (TTM) | US$1.33m |
0.0x
P/S Ratio0.0x
P/E RatioIs ORVR.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ORVR.F income statement (TTM) | |
|---|---|
| Revenue | US$1.33m |
| Cost of Revenue | US$1.31m |
| Gross Profit | US$24.20k |
| Other Expenses | US$3.18m |
| Earnings | -US$3.16m |
Last Reported Earnings
Mar 31, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did ORVR.F perform over the long term?
See historical performance and comparison